Our Services
Medical Information
Helpful Resources
Published on: 4/5/2026
Gabapentin in pregnancy is generally not strongly linked to major birth defects, but there are several factors to consider; late pregnancy use may slightly increase risks of preterm birth, low birth weight, NICU care, and newborn withdrawal, especially when combined with opioids.
Do not stop it suddenly; work with your clinician on a personalized plan that weighs benefits against risks, explores dose adjustments and non drug options, and addresses breastfeeding monitoring and timing near delivery, and see the detailed guidance below to inform your next steps.
Gabapentin is a medication commonly prescribed for chronic pain, nerve pain (neuropathy), seizures, and sometimes anxiety disorders. If you are pregnant—or planning to become pregnant—and taking gabapentin, it's natural to have questions about safety, fetal development, and potential risks.
This guide explains what current medical evidence says about gabapentin in pregnancy, including known gabapentin side effects, potential risks to the baby, and how to make informed decisions with your healthcare provider.
Gabapentin is an anticonvulsant medication. It works by calming overactive nerve signals in the brain and body. Doctors most often prescribe it for:
Because chronic pain can significantly affect sleep, mood, and overall health, stopping medication abruptly can sometimes cause more harm than benefit—especially during pregnancy.
During pregnancy, medications may cross the placenta and reach the developing fetus. The first trimester (weeks 1–12) is particularly important because major organs are forming.
When evaluating gabapentin use in pregnancy, doctors consider:
It's rarely a simple yes-or-no decision. Instead, it's about balancing risks and benefits.
Gabapentin is not classified as a high-risk medication for birth defects, but it is also not considered completely risk-free.
Large observational studies have generally not shown a major increase in overall birth defects with gabapentin use during early pregnancy. However:
Importantly, untreated epilepsy or severe chronic pain can also pose risks to both mother and baby. For women taking gabapentin for seizures, stopping medication without supervision can be dangerous.
Some studies have suggested that gabapentin use later in pregnancy may be associated with:
However, it is not always clear whether these outcomes are caused by the medication itself or the underlying health condition being treated.
There have been reports of newborns experiencing withdrawal symptoms if gabapentin was used near delivery, especially when combined with opioids.
Symptoms in newborns may include:
These symptoms are generally manageable in a hospital setting but should be anticipated if gabapentin is continued late into pregnancy.
Understanding gabapentin side effects is important during pregnancy because some may overlap with pregnancy symptoms.
Common gabapentin side effects include:
Less common but more serious side effects include:
Pregnancy can already increase fatigue, swelling, and balance issues. Gabapentin may intensify these effects, increasing fall risk.
If you experience:
you should seek urgent medical care and speak to a doctor immediately.
It's easy to focus only on medication risks, but untreated chronic pain can also affect pregnancy outcomes.
Poorly controlled pain may lead to:
Chronic stress during pregnancy has been associated with preterm birth and other complications. For some women, staying on gabapentin provides better overall stability.
If you're experiencing persistent pain symptoms and want to better understand your condition, Ubie's free AI-powered Chronic Pain Symptom Checker can help you identify potential causes and prepare informed questions for your healthcare provider before making any treatment decisions.
Do not stop gabapentin suddenly without medical guidance.
Abrupt discontinuation can cause:
Instead, talk to your doctor about:
Every pregnancy is unique. A personalized plan is essential.
Depending on your diagnosis, your doctor may suggest additional or alternative strategies, such as:
Never switch medications without professional guidance.
Gabapentin does pass into breast milk in small amounts. Current evidence suggests:
Discuss breastfeeding plans with your pediatrician and OB-GYN to ensure coordinated care.
When discussing gabapentin during pregnancy, consider asking:
Clear communication reduces uncertainty and supports informed decisions.
Based on current medical evidence:
There is no universal recommendation that all pregnant women must stop gabapentin. The right decision depends on your health history, symptom severity, and pregnancy stage.
Contact a doctor immediately if you experience:
Anything that feels life-threatening or serious should be evaluated right away.
Navigating gabapentin use during pregnancy requires thoughtful discussion—not panic. While research suggests that the overall risk of major birth defects is low, gabapentin side effects and possible pregnancy-related complications must be weighed against the consequences of untreated pain or seizures.
The safest path forward is a personalized plan created with your healthcare provider. Never adjust or stop medication without guidance.
If you are managing chronic pain and considering pregnancy—or already pregnant—schedule an appointment to review your medications as soon as possible. Speak to a doctor about any symptoms that could be serious or life-threatening.
With careful monitoring and informed decision-making, many women using gabapentin go on to have healthy pregnancies and healthy babies.
(References)
* Patorno E, Bohnert ASB, Hernández-Díaz S, et al. Gabapentin use in pregnancy and the risk of adverse pregnancy and fetal outcomes: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2020;29(8):937-947.
* Patorno E, Bohnert ASB, Hernández-Díaz S, et al. Association of Gabapentin Exposure in Pregnancy With Major Congenital Malformations. JAMA Neurol. 2020;77(11):1343-1351.
* Winterfeld U, Schüler C, Moser C, et al. Gabapentin Use in Pregnancy and the Risk of Adverse Pregnancy Outcomes: A Population-Based Study. Epilepsia. 2015;56(11):1858-1865.
* Schaefer C, Scholl L, Weber-Schoendorfer C. Gabapentin exposure in pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2017;69:10-15.
* Molgaard-Nielsen D, Larsson M, Hellgren E. Risks for the offspring of gabapentin use during pregnancy: a population-based cohort study. BMJ. 2014;348:f3348.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.